ACE Report Cover
Local infiltration analgesia does not reduce PCA use after periacetabular osteotomy
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Lingua
Download Download Download
Scaricare
Cite this Report Cite this Report Cite this Report
Citare
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Preferiti
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Lingua
Download Download Download
Scaricare
Cite this Report Cite this Report Cite this Report
Citare
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Preferiti
GENERAL ORTHOPAEDICS
Local infiltration analgesia does not reduce PCA use after periacetabular osteotomy .

OrthoEvidence Journal (OE Journal) - ACE Report

OE Journal. 2014;2(13):14 Acta Orthop. 2014 Apr;85(2):141-6
Autori che hanno contribuito

RD Bech O Ovesen P Lindholm S Overgaard

Seventy patients scheduled to undergo periacetabular osteotomy were randomized either to receive or not receive local infiltration analgesia (LIA) with ropivacaine intra- and postoperatively. As all patients were treated with opioid based patient-controlled analgesia (PCA) postoperatively, the purpose was to determine whether LIA was effective at reducing the need for PCA (oxycodone) postoperatively. Over the first 4 postoperative days, there was no significant difference between groups in oxycodone consumption.


Dettagli sul finanziamento della pubblicazione +
Finanziamento:
Non-Industry funded
Sponsor:
Odense University Hospital; Region of Southern Denmark Research; The Aase and Ejnar Danielsen Foundation
Conflicts:
None disclosed

Rischio di pregiudizio

7,5/10

Criteri di segnalazione

16/20

Indice di fragilità

N/A

Was the allocation sequence adequately generated?

Was allocation adequately concealed?

Blinding Treatment Providers: Was knowledge of the allocated interventions adequately prevented?

Blinding Outcome Assessors: Was knowledge of the allocated interventions adequately prevented?

Blinding Patients: Was knowledge of the allocated interventions adequately prevented?

Was loss to follow-up (missing outcome data) infrequent?

Are reports of the study free of suggestion of selective outcome reporting?

Were outcomes objective, patient-important and assessed in a manner to limit bias (ie. duplicate assessors, Independent assessors)?

Was the sample size sufficiently large to assure a balance of prognosis and sufficiently large number of outcome events?

Was investigator expertise/experience with both treatment and control techniques likely the same (ie.were criteria for surgeon participation/expertise provided)?

Sì = 1

Incerto = 0,5

Non rilevante = 0

No = 0

La valutazione dei criteri di segnalazione valuta la trasparenza con cui gli autori riportano le caratteristiche metodologiche e sperimentali dello studio all'interno della pubblicazione. La valutazione è suddivisa in cinque categorie che vengono presentate di seguito.

1/4

Randomization

3/4

Outcome Measurements

4/4

Inclusion / Exclusion

4/4

Therapy Description

4/4

Statistics

Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65

L'Indice di Fragilità è uno strumento che aiuta l'interpretazione dei risultati significativi, fornendo una misura della forza di un risultato. L'Indice di Fragilità rappresenta il numero di eventi consecutivi che devono essere aggiunti a un risultato dicotomico per rendere il risultato non più significativo. Un numero piccolo rappresenta un risultato più debole, mentre un numero grande rappresenta un risultato più forte.

Perché questo studio era necessario ora?

Postoperative pain is often considerable following periacetabular osteotomy, requiring analgesia. Current methods of pain management include a psoas block, patient-controlled analgesia (PCA), and continuous epidural and spinal analgesia. While these treatments often lower pain experienced postoperatively, their associated side-effects have prompted researchers to consider alternative methods. Local infiltration analgesia has demonstrated efficacy in total knee and hip arthroplasty procedures, although its role in periacetabular osteotomy has yet to be established.

Qual era la domanda di ricerca principale?

What is the efficacy of local infiltration analgesia (LIA) with ropivacaine for postoperative analgesia following periacetabular osteotomy, assessed over the first 4 postoperative days?

Caratteristiche dello studio +
Population:
Seventy patients with hip dysplasia or a retroverted acetabulum and scheduled for periacetabular osteotomy. All surgeries were performed using a modified Smith-Petersen approach and the same surgical technique. Drains were not used.
Intervention:
LIA group: Intraoperatively, 75mL ropivacaine (150mg) was administered to all tissues incised or instrumented during the procedure. Prior to the end of the procedure, a catheter was placed within the surgical site in order to allow for postoperative injections of LIA. Five injections of 20mL ropivacaine (50mg) were administered at 10 hour intervals following surgery, after which the catheter was removed. Patients also received postoperative PCA initiated in the recovery room with bolus morphine IV injections and switched to oxycodone (5mg) when patients were able to consume tablets (Mean age: 35 [range 18-54]; 9M/17F; n=35; 26 completed)
Comparison:
Placebo group: Intraoperatively, 75mL of isotonic saline was administered to all tissues incised or instrumented during the procedure. Prior to the end of the procedure, a catheter was placed within the surgical site in order to allow for postoperative injections of LIA. Five injections of 20mL saline were administered at 10 hour intervals following surgery, after which the catheter was removed. Patients also received postoperative PCA initiated in the recovery room with bolus morphine IV injections and switched to oxycodone (5mg) when patients were able to consume tablets (Mean age: 31 [range 18-55]; 3M/24F; n=35; 27 completed)
Outcomes:
Primary outcome was consumption of patient-controlled analgesia. Visual analog scales were used to assess pain (at rest and with activity) and nausea. Mobility was evaluated using the Timed Up-And-Go (TUG) test.
Methods:
RCT; Double-blind, Placebo-controlled, Prospective
Time:
Follow-up conducted during the first 4-day postoperative period.
Quali erano i risultati importanti?
  • There were no significant differences between the LIA and placebo group for oxycodone consumption over the first 4 PODs (POD1 p=0.66; POD2 p=0.86; POD3 p=0.57; POD4 p=0.85).
  • VAS pain scores at rest were similar between groups 6h after surgery and on POD 1 (p=0.1 and 0.2, respectively). The LIA group demonstrated significantly lower mean pain scores at rest than the placebo group on POD2 (24 vs. 31), POD3 (19 vs. 31) and POD4 (18 vs. 28) (p<0.05).
  • No significant differences in the TUG test or pain after the TUG test were noted between groups for the duration of the 4-day observation period (all p>0.05).
  • Antiemetic use was similar between groups for the duration of the placement of the catheter.
Che cosa devo ricordare di più?

Consumption of patient-controlled analgesia following periacetabular osteotomy was not decreased with the infiltration of ropivacaine at the end of surgery and for 2 days postoperatively.

Come influenzerà l'assistenza ai miei pazienti?

From these findings, it would appear that local infiltration of ropivacaine alone is not sufficient to reduce the need for patient-controlled analgesia after periacetabular osteotomy, and that adverse events associated with opioid PCA (postoperative nausea and vomiting) would not be expected to decrease from its implementation. Whether LIA ropivacaine is an efficacious component in mulitmodal analgesia for periacetabular osteotomy remains to be determined in future studies.

DISCLAIMER

Il contenuto di questa pagina è solo a scopo informativo e non intende sostituire la consulenza, la diagnosi o il trattamento medico professionale. Se ha bisogno di cure mediche, si rivolga sempre al suo medico o al pronto soccorso più vicino. Le opinioni, le convinzioni e i punti di vista espressi dalle persone sui contenuti presenti in questa pagina non riflettono le opinioni, le convinzioni e i punti di vista di OrthoEvidence.

0 di 4 articoli mensili GRATUITI sbloccati
Ha raggiunto il suo limite di 4 visualizzazioni di articoli gratuiti questo mese

Accesso a OrthoEvidence a soli 1,99 dollari a settimana.

Rimanga in contatto con le ultime prove. Può disdire in qualsiasi momento.
  • Valutazioni critiche dei più recenti studi randomizzati controllati ad alto impatto e delle revisioni sistematiche in ortopedia.
  • Accesso ai contenuti del podcast OrthoEvidence, tra cui collaborazioni con il Journal of Bone and Joint Surgery, interviste con chirurghi di fama internazionale e tavole rotonde su notizie e argomenti ortopedici.
  • Abbonamento a The Pulse, una newsletter bisettimanale basata sulle evidenze scientifiche, progettata per aiutarla a prendere decisioni cliniche migliori.
Upgrade
Bentornato!
Ha dimenticato la password?
Inizi la sua prova gratuita oggi stesso!

Il suo account sarà affiliato a
e includerà l'accesso gratuito a OrthoEvidence


O
Ha dimenticato la password?

O
Controlli la sua e-mail

Se esiste un account con l'indirizzo e-mail fornito, le verrà inviata un'e-mail di reimpostazione della password. Se non vede l'e-mail, controlli la cartella spam o posta indesiderata.

Per ulteriore assistenza, contatti il nostro team di supporto.

Effettui il login per abilitare questa funzione

Per accedere a questa funzione, deve essere collegato ad un account OrthoEvidence attivo. Effettui il login o crei un account di prova GRATUITO.

Tradurre il Rapporto ACE

OrthoEvidence utilizza un servizio di traduzione di terze parti per rendere i contenuti accessibili in più lingue. Si prega di notare che, sebbene venga fatto ogni sforzo per garantire l'accuratezza, le traduzioni potrebbero non essere sempre perfette.

Come citare questo documento ACE Report

OrthoEvidence. Local infiltration analgesia does not reduce PCA use after periacetabular osteotomy. OE Journal. 2014;2(13):14. Available from: https://myorthoevidence.com/AceReport/Show/

Copiare la citazione
Effettui il login per abilitare questa funzione

Per accedere a questa funzione, deve essere collegato ad un account OrthoEvidence attivo. Effettui il login o crei un account di prova GRATUITO.

Funzionalità per i membri Premium

Per accedere a questa funzione, deve essere collegato ad un account OrthoEvidence Premium.

Condividi questo articolo ACE Report